Showing results (311-320 of 422) with videos related to

Sort By:
Pageof 43
Annals of Neurology|February 15, 2021
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSDDean M Wingerchuk, Kazuo Fujihara, Jacqueline Palace, et al.
The New England Journal of Medicine|April 9, 2025
Tolebrutinib versus Teriflunomide in Relapsing Multiple SclerosisJiwon Oh, Douglas L Arnold, Bruce A C Cree, et al.
Scientific Reports|February 2, 2019
Integrative metabolomics reveals unique metabolic traits in Guillain-Barré Syndrome and its variantsSoo Jin Park, Jong Kuk Kim, Hyun-Hwi Kim, et al.
The American Journal of Cardiology|December 17, 2019
Computed Tomography Features of Cuspal Thrombosis and Subvalvular Tissue Ingrowth after Transcatheter Aortic Valve ImplantationHyun Jung Koo, Jooae Choe, Do-Yoon Kang, et al.
The American Journal of Cardiology|June 15, 2021
Incidence, Predictors, and Prognostic Impact of Immediate Improvement in Left Ventricular Systolic Function After Transcatheter Aortic Valve ImplantationYeong Jin Jeong, Jung-Min Ahn, Do-Yoon Kang, et al.
Disease Markers|July 2, 2010
Lack of association between PRNP M129V polymorphism and multiple sclerosis, mild cognitive impairment, alcoholism and schizophrenia in a Korean populationIhn-Geun Choi, Sung-Il Woo, Ho Jin Kim, et al.
Neurology|February 16, 2024
Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy: A Retrospective Observational StudyKi Hoon Kim, Moowan Park, Eun Young Park, et al.
Multiple Sclerosis and Related Disorders|March 6, 2021
Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extensionHo Jin Kim, Ichiro Nakashima, Shanthi Viswanathan, et al.
Annals of Neurology|March 3, 2023
Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum DisorderSean J Pittock, Michael Barnett, Jeffrey L Bennett, et al.
Experimental & Molecular Medicine|April 14, 2018
Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke modelSeung-Hun Oh, Chunggab Choi, Jeong-Eun Noh, et al.
Pageof 43